Notes in HNSCC General

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	H&N \| HNSCC General \| 1.2 \| Epidemiology \| Describe the epidemiology of H&N SCC
Published	02/18/2024	H&N \| HNSCC General \| 1.1.1 \| Anatomy \| Surface anatomy \| Face \| Fill in the labels \|
Published	02/18/2024	H&N \| HNSCC General \| 1.1.3 \| Anatomy \| Surface anatomy \| Nose
Published	02/18/2024	H&N \| HNSCC General \| 1.1.2 \| Anatomy \| Surface anatomy \| Fill in the labels \|
Published	02/18/2024	H&N \| HNSCC General \| 1.1.4 \| Anatomy \| Surface anatomy \| Oral cavity \| Fill in the labels \|
Published	02/18/2024	H&N \| HNSCC General \| 1.1.5 \| Anatomy \| Surface anatomy \| Ear \| Fill in the labels \|
Published	02/18/2024	H&N \| HNSCC General \| 1.1.5 \| Anatomy \| Surface anatomy \| Neck triangles \| Fill in the labels \|
Published	02/18/2024	H&N \| HNSCC General \| 1.1.6 \| Anatomy \| Surface anatomy \| LN levels \| Fill in the labels \|
Published	02/18/2024	H&N \| HNSCC General \| 5.2 \| Systemic therapy for recurrent and metastatic H&N SCC \| Scope, general treatment options, decision factors, p…
Published	02/18/2024	H&N \| HNSCC General \| 5.4.1 \| Systemic therapy for recurrent and metastatic H&N SCC \| Immunotherapy
Published	02/18/2024	H&N \| HNSCC General \| 5.3 \| Systemic therapy for recurrent and metastatic H&N SCC \| Cytotoxic chemo
Published	02/18/2024	H&N \| HNSCC General \| 5.1 \| Systemic therapy for recurrent and metastatic H&N SCC \| Treatment algorithm
Published	02/18/2024	H&N \| HNSCC General \| 5.5 \| Systemic therapy for recurrent and metastatic H&N SCC \| Ongoing trials
Published	02/18/2024	H&N \| HNSCC General \| 7 \| Patterns of relapse
Published	02/18/2024	H&N \| HNSCC General \| 5.4.2 \| Immunotherapy resources
Published	02/18/2024	H&N \| HNSCC General \| 8 \| PET scans
Published	02/18/2024	H&N \| HNSCC General \| 6 \| Swallowing management in H&N cancer
Published	02/18/2024	H&N \| HNSCC General \| 4.1 \| Locoregional recurrence \| Management overview
Published	02/18/2024	H&N \| HNSCC General \| 4.2 \| Locoregional recurrence \| Natural history
Published	02/18/2024	H&N \| HNSCC General \| 4.3 \| Locoregional recurrence \| Workup and treatment decision factors
Published	02/18/2024	H&N \| HNSCC General \| 4.4 \| Locoregional recurrence \| Prognosis
Published	02/18/2024	H&N \| HNSCC General \| 4.5.1 \| Locoregional recurrence \| Surgery
Published	02/18/2024	H&N \| HNSCC General \| 4.5.2 \| Locoregional recurrence \| Postoperative radiotherapy
Published	02/18/2024	H&N \| HNSCC General \| 4.6 \| Locoregional recurrence \| Re-irradiation \| Conventional RT
Published	02/18/2024	H&N \| HNSCC General \| 4.7 \| Locoregional recurrence \| Re-irradiation \| SBRT
Published	02/18/2024	H&N \| HNSCC General \| 4.8 \| Locoregional recurrence \| Re-irradiation \| Brachytherapy
Published	02/18/2024	H&N \| HNSCC General \| 2.4.2 \| PORT \| Postoperative chemoradiotherapy
Published	02/18/2024	H&N \| HNSCC General \| 3.2 \| RT \| Palliative \| QUAD SHOT
Published	02/18/2024	H&N \| HNSCC General \| 3.3 \| RT \| Palliative \| "Hypo trial" 30Gy/5# (twice weekly)
Published	02/18/2024	H&N \| HNSCC General \| 3.1 \| RT \| Palliative \| Rationale, outcomes, regimes
Published	02/18/2024	H&N \| HNSCC General \| 2.4.1 \| PORT \| Postoperative radiotherapy alone
Published	02/18/2024	H&N \| HNSCC General \| 2.4.3 \| PORT \| Dose and fractionation
Published	02/18/2024	H&N \| HNSCC General \| 2.5.3 \| Definitive RT \| Altered fractionation (RT alone) \| Summary
Published	02/18/2024	H&N \| HNSCC General \| 2.6 \| Definitive RT \| Altered fractionation + concurrent chemo
Published	02/18/2024	H&N \| HNSCC General \| 1.3 \| Risk factors
Published	02/18/2024	H&N \| HNSCC General \| 1.4 \| HPV associated H&N cancer
Published	02/18/2024	H&N \| HNSCC General \| 1.5.1 \| Pathology \| Molecular pathogenesis
Published	02/18/2024	H&N \| HNSCC General \| 1.5.2 \| Pathology \| Clinical pre-invasive lesions \| Leukoplakia and erythroplakia
Published	02/18/2024	H&N \| HNSCC General \| 1.5.3 \| Pathology \| Pre-invasive lesions \| Squamous hyperplasia and dysplasia
Published	02/18/2024	H&N \| HNSCC general \| 1.6.1 \| Field cancerisation
Published	02/18/2024	H&N \| HNSCC General \| 1.7 \| Clinical presentation
Published	02/18/2024	H&N \| HNSCC General \| 1.8 \| Workup
Published	02/18/2024	H&N \| HNSCC General \| 1.9 \| Dental assessment and oral care
Published	02/18/2024	H&N \| HNSCC general \| 2.1 \| Management \| General principles
Published	02/18/2024	H&N \| HNSCC General \| 2.2 \| Management Overview
Published	02/18/2024	H&N \| HNSCC General \| 2.3.1 \| Surgery \| Pre-operative assessment
Published	02/18/2024	H&N \| HNSCC General \| 2.3.2 \| Surgery \| Neck dissection
Published	02/18/2024	H&N \| HNSCC General \| 2.5.1 \| Definitive RT \| Conventional fracionation \| Dose table
Published	02/18/2024	H&N \| HNSCC General \| 2.5.2.1 \| Definitive RT \| Altered fractionation \| Hyperfractionation
Published	02/18/2024	H&N \| HNSCC General \| 2.5.2.2.1 \| Definitive RT \| Altered fractionation \| Accelerated fractionation \| Principles
Published	02/18/2024	H&N \| HNSCC General \| 2.5.2.2.2 \| Definitive RT \| Altered fractionation \| Accelerated fractionation \| Pure acceleration
Published	02/18/2024	H&N \| HNSCC General \| 2.5.2.2.3 \| Definitive RT \| Altered fractionation \| Accelerated fractionation \| Hyperfractionated acceleration
Published	02/18/2024	H&N \| HNSCC General \| 2.5.2.2.4 \| Definitive RT \| Altered fractionation \| Accelerated fractionation \| Split course hyperfractionated accelera…
Published	02/18/2024	H&N \| HNSCC General \| 2.5.2.2.5 \| Definitive RT \| Altered fractionation \| Accelerated fractionation \| Split course hyperfractionated accelera…
Published	02/18/2024	H&N \| HNSCC General \| 2.7 \| Definitive RT \| Sequential (induction) chemotherapy
Published	02/18/2024	H&N \| HNSCC General \| 2.8.1.1 \| Definitive RT \| Concurrent chemotherapy \| Comparison to other strategies
Published	02/18/2024	H&N \| HNSCC General \| 2.8.2 \| Definitive RT \| Concurrent Cetuximab
Published	02/18/2024	H&N \| HNSCC General \| 2.8.3.1 \| Definitive RT \| Hypoxia \| Hypoxic cell sensitisers
Published	02/18/2024	H&N \| HNSCC General \| 2.8.3.2 \| Definitive RT \| Hypoxia \| Hypoxic cell cytotoxins
Published	02/18/2024	H&N \| HNSCC General \| 2.9.1 \| Management of the neck \| N0 neck
Published	02/18/2024	H&N \| HNSCC General \| 2.9.2 \| Management of the neck \| N1-3 neck
Published	02/18/2024	H&N \| HNSCC General \| 2.9.3 \| Management of the neck \| Radiation induced fibrosis
Published	02/18/2024	H&N \| HNSCC General \| 2.8.1.2 \| Definitive RT \| Concurrent chemotherapy \| Choice of schedule
Status	Last Update	Fields